PCSK9通过通过YAP1-NUPR1轴诱导VSMC铁死,促进动脉样板不稳定
Yuting Cui1,2, Yanyu Chen1,3, HengJuan Li1
1Institute of Cardiovascular Disease, Key Laboratory for Arteriosclerology of Hunan Province, Hunan Intern Scientific and Technological Cooperation Base of Arteriosclerotic Disease, School of Basic Medical Sciences, Hengyang Medical School, University of South China, Hengyang 421001, Hunan, China.
Research (Washington, D.C.)
|October 9, 2025
概括
蛋白转化酶亚提利辛/凯辛9型 (PCSK9) 通过增加血管光滑肌细胞 (VSMCs) 的铁亡,促进动脉样硬化斑块的不稳定性. 向PCSK9可能会稳定斑块并减少主要不良心血管事件 (MACE).
科学领域:
- 心血管生物学 心血管生物学
- 疾病的细胞机制.
- 分子心脏病学分子心脏病学
背景情况:
- 动脉样硬化是心血管死亡的主要原因,由斑块不稳定性驱动.
- 脆弱的动脉样硬化斑块可能会破裂,导致主要的不良心血管事件 (MACE).
- 蛋白转化酶亚素/素9型 (PCSK9) 主要以脂质调节而闻名,但其在斑块不稳定中的作用正在研究中.
研究的目的:
- 研究PCSK9在血管光滑肌细胞 (VSMC) 中的非正规作用及其对动脉样硬化斑块不稳定性的影响.
- 阐明PCSK9影响VSMC命运和斑块脆弱性的分子机制.
主要方法:
- 研究了PCSK9对VSMC铁亡的作用.
- 研究了PCSK9,YAP1和核因子1 (NF1) 之间的相互作用.
- 利用细胞模型来评估斑块的脆弱性.
主要成果:
- 过度活跃的PCSK9显著促进VSMCs中的ferroptotic细胞死亡.
- 这种铁亡加剧了动脉样硬化斑块的脆弱性.
- PCSK9与YAP1相互作用,导致其溶酶体降解,随后抑制NF1的表达.
结论:
- PCSK9通过诱导VSMC铁亡,在促进斑块不稳定性方面发挥着新的作用.
- 向PCSK9提供了一个潜在的治疗策略来稳定斑块.
- 这种方法可以帮助减轻主要不良心血管事件 (MACE) 的发生率.
相关概念视频
Atherosclerosis I: Introduction
916
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
916
Coronary Artery Disease II: Pathophysiology
367
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
367
Cholesterol: Significance and Regulation
1.2K
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
1.2K
Regulation of Nuclear Protein Sorting
3.2K
Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...
3.2K
Atherosclerosis III: Management
319
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
319
Pinching-off of Coated Vesicles
4.0K
Vesicle budding is orchestrated by distinct cytosolic proteins such as adaptor proteins, coat proteins, and GTPases. To initiate vesicle budding, membrane-bending proteins containing crescent-shaped BAR domains bind to the lipid heads in the bilayer and distort the membrane to form a protein-coated vesicle bud. Adaptors proteins such as AP2 for clathrin-coated vesicles can nucleate on the deformed membrane. Finally, coat proteins such as clathrin or COPI and COPII assemble into a coat forming...
4.0K


